Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells.

The Embryonic Stem Cell Test (EST) has been successfully validated as an in vitro method for detecting embryotoxicity, showing a good overall test accuracy of 78% [Genschow, E., Spielmann, H., Scholz, G., Seiler, A., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., Becker, K., 2002. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern. Lab. Anim. 30, 151-176]. Methylmercury was the only strong in vivo embryotoxicant falsely predicted as non-embryotoxic making the metal the most significant outlayer [Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S., Becker, K., 2004. Validation of the Embryonic Stem Cell Test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 32, 209-244]. The misclassification of methylmercury and the potential environmental exposure to developmental toxic heavy metals promoted our investigation of whether the EST applicability domain covers cadmium and arsenic compounds. The EST misclassified cadmium, arsenite and arsenate compounds as non-embryotoxic, even when including arsenic metabolites (methylarsonate, methylarsonous and dimethylarsinic). The reasons were the lack of higher cytotoxicity towards embryonic stem cells as compared to more mature cells (3T3 fibroblasts) or the absence of inhibition of cardiac differentiation by specific mechanisms rather than general cytotoxicity. Including EST data on heavy metals from the literature (lithium, methylmercury, trivalent chromium and hexavalent chromium) revealed that the test correctly predicted the embryotoxic potential of three out of the seven heavy metals, indicating an insufficient predictivity for such metals. Refinement of the EST prediction model and inclusion of additional toxicological endpoints could expand the applicability domain and enhance the predictive power of the test.

[1]  S. Bremer,et al.  Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells. , 2007, Toxicology.

[2]  M. Rosen,et al.  Effects of chemically induced maternal toxicity on prenatal development in the rat. , 1990, Teratology.

[3]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[4]  Aldert Piersma,et al.  The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[5]  D. DeMarini,et al.  Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations , 2003, Environmental and molecular mutagenesis.

[6]  R. Kavlock,et al.  The teratogenic potential of cacodylic acid in the rat and mouse. , 1981, Drug and chemical toxicology.

[7]  N. Brown.  Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests , 2002, Alternatives to laboratory animals : ATLA.

[8]  J. Domingo.  Metal-induced developmental toxicity in mammals: a review. , 1994, Journal of toxicology and environmental health.

[9]  C. Willhite.  Arsenic-induced axial skeletal (dysraphic) disorders. , 1981, Experimental and molecular pathology.

[10]  M. Vahter.  Mechanisms of arsenic biotransformation. , 2002, Toxicology.

[11]  J. DeSesso,et al.  Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment. , 2006, Birth defects research. Part B, Developmental and reproductive toxicology.

[12]  R. Hood,et al.  Evaluation of arsenic metabolites for prenatal effects in the hamster , 1982, Bulletin of environmental contamination and toxicology.

[13]  B. D. Beck,et al.  Methylated Arsenicals: The Implications of Metabolism and Carcinogenicity Studies in Rodents to Human Risk Assessment , 2006, Critical reviews in toxicology.

[14]  R. Hood.  Developmental Effects of Methylated Arsenic Metabolites in Mice , 1998, Bulletin of environmental contamination and toxicology.

[15]  H. Aposhian,et al.  A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. , 2004, Toxicology and applied pharmacology.

[16]  M. Golub,et al.  Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. , 1998, Journal of toxicology and environmental health. Part B, Critical reviews.

[17]  J. Nriagu,et al.  Quantitative assessment of worldwide contamination of air, water and soils by trace metals , 1988, Nature.

[18]  James L. Schardein,et al.  Chemically Induced Birth Defects , 1985 .

[19]  Aldert Piersma,et al.  The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.

[20]  A. Hirner,et al.  Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. , 2004, Toxicology and applied pharmacology.

[21]  S. Bremer,et al.  Detection of the Embryotoxic Potential of Cyclophosphamide by Using a Combined System of Metabolic Competent Cells and Embryonic Stem Cells , 2002, Alternatives to laboratory animals : ATLA.

[22]  Elke Genschow,et al.  Embryotoxicity Screening Using Embryonic Stem Cells in vitro: Correlation to in vivo Teratogenicity , 1999, Cells Tissues Organs.